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Abstract
Background: In obesity, phenotypic switches occur in macrophage populations such that the predominantly
M2-polarised anti-inflammatory state seen in lean individuals changes to a predominantly M1-polarised
pro-inflammatory state in those who are obese. However, the mechanisms by which these phenotypic shifts occur
have not yet been fully elucidated.
Results: The effects of oxLDL (1-40 μg/ml; 24 h) on several parameters relevant to the Unfolded Protein Response
(UPR)-mediated lipotoxic effects of oxLDL (disruption of ER Ca
2+ handling; activation of the UPR transcription factor
XBP-1; upregulation of the UPR target genes BiP and CHOP; apoptosis; cell viability) were investigated in human
primary monocyte-derived macrophages, and also in monocyte-macrophages derived from the THP-1 monocytic
cell line. A consistent pattern was observed: M2-polarised macrophages were more sensitive to the lipotoxic effects
of oxLDL than either non-polarised macrophages or non-differentiated monocytic cells. Specifically, M2-polarised
macrophages were the only cell type to undergo significantly increased apoptosis (Primary cells: 1.23 ± 0.01 basal;
THP-1-derived: 1.97 ± 0.12 basal; P < 0.05 in both cases) and decreased cell viability (Primary cells: 0.79 ± 0.04 basal;
THP-1-derived: 0.67 ± 0.02 basal; P < 0.05 in both cases) when exposed to oxLDL levels similar to those seen in
overweight individuals (ie. 1 μg/ml).
Conclusions: We propose that the enhanced susceptibility of M2-polarised macrophages to lipotoxicity seen in the
present in vitro study could, over time, contribute to the phenotypic shift seen in obese individuals in vivo. This is
because a higher degree of oxLDL-induced lipotoxic cell death within M2 macrophages could contribute to a
decrease in numbers of M2 cells, and thus a relative increase in proportion of non-M2 cells, within macrophage
populations. Given the pro-inflammatory characteristics of a predominantly M1-polarised state, the data presented
here may constitute a useful contribution to our understanding of the origin of the pro-inflammatory nature of
obesity, and of the pathogenesis of obesity-associated inflammatory disorders such as Type 2 Diabetes and
atherosclerosis.
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Background
Obesity and associated disorders such as Type-2 Diabetes
(T2D) and atherosclerosis are associated with elevated
levels of many lipids (eg. increased circulating oxidized
low-density lipoprotein (oxLDL) [1,2]), and with chronic
inflammation [3]. This can lead to intracellular lipid
accumulation in non-adipocyte cells, which can in turn
lead to cell death, a phenomenon known as “lipotoxicity”
[2].
Due to their wide tissue distribution, monocyte/macro-
phages, which play vital roles in inflammation and the
development of obesity, T2D and atherosclerosis [3], are
involved in lipid accumulation within many tissues [4]. For
example, the intracellular accumulation of oxLDL within
macrophages is mediated by scavenger receptors (such as
CD36, SR-A and possibly SR-BI, although the role of the
latter is currently controversial [5]) recognizing altered
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modified lipoproteins such as acetylated LDL (as distinct
from non-oxidised LDL), and facilitating its uptake [6].
Two distinct subpopulations of monocyte/macrophages
have been identified that exhibit different physiological
properties: Th1 cytokines (eg. interferon-g and interleu-
kin-1b) promote polarisation into proinflammatory “classi-
cal” (M1) macrophages, while Th2 cytokines (eg.
interleukin-4, interleukin-13) induce polarisation into anti-
inflammatory “alternative” (M2) macrophages [7,8]. M2
differentiation is associated with suppressed release of
pro-inflammatory mediators [8], enhanced oxidative meta-
bolism [9], and increased mitochondrial biogenesis [10].
Conversely, reductions in M2 differentiation correlate with
disruptions in cholesterol homeostasis and reverse choles-
terol transport [11], and to increases in total body fat
mass, adiposity, glucose intolerance, and insulin resistance
[10]. These findings led Odegaard et al to suggest that
“macrophage polarisation towards the alternative [M2]
state may be a useful strategy for treating T2D“ [10].
Macrophage populations resident in adipose tissue
upon high-fat feeding exhibit an M1-predominant state
different from that of the M2-predominant population
residing in adipose tissue under normal dietary condi-
tions [12]. Moreover, similar phenotypic shifts have been
reported for free cholesterol-loaded peritoneal macro-
phages in-vitro [13]. Mechanisms responsible for such
obesity-linked shifts to predominantly M1 cells include
increased infiltration of M1 cells from the circulation [1],
and differentiation of mesenchymal stem cells into M1
cells (or trans-differentation of M2 cells into M1 cells)
within adipose tissue [11]. Also, circulating peripheral
blood monocytes can be primed for differentiation into
functionally distinct macrophage subpopulations in cer-
tain circumstances, such as PPARg-mediated priming of
circulating monocytes for differentiation towards an anti-
inflammatory M2 macrophage phenotype [8,14]. How-
ever, additional mechanism(s) may also underpin the
M2-to-M1 shifts seen within pre-existing macrophage
populations during the development of obesity [4]; for
example, a recent report has suggested that “lipid-
induced toxicity is an important determinant of the
obesity-linked proinflammatory switch in macrophage
polarisation“ [15].
The endoplasmic reticulum (ER) is a key organelle with
regard to lipotoxicity in macrophages, as trafficking of
free cholesterol to the ER membrane and incorporation
of cholesterol into the normally cholesterol-poor ER
membrane alters the physico-chemical properties of this
membrane and leads to disruption of ER functions [16].
Disturbance of ER functions leads to the ER becoming
overwhelmed with accumulated unfolded proteins, and
under such conditions of ER stress, the cell responds by
initiating an “unfolded protein response” (UPR [17]). The
UPR involves either generalised inhibition of translation
combined with specific upregulation of UPR genes that
restore the ER’s ability to function (eg. binding immuno-
globulin protein (BiP; a.k.a. GRP78); [18]), or activation
of the pro-apoptotic C/EBP homologous protein (CHOP)
pathway [19] if these actions fail to resolve the original
ER stress. Hence, UPRs lead either to restoration of nor-
mal cell physiology and cell survival, or to cell death [17].
Thus, excessive accumulation of cholesterol into macro-
phages can lead via UPR/CHOP-triggered apoptosis to
lipotoxic macrophage cell death [20,21]; importantly, we
and others have recently reported that oxLDL can trigger
similar effects [22,23], due to liberation of free cholesterol
from oxLDL particles that have been imported into
macrophages, and trafficking of this free cholesterol to
the ER membrane [16,20,23].
In the present study, we hypothesised that differential
sensitivity of M2 macrophages to elevated levels of oxLDL
in obesity, and thus to more frequent lipotoxic cell death
of M2 cells, may contribute to the decrease in proportion
of M2 cells seen within the macrophage population in
obese individuals. Thus, using both primary cells and cells
derived from the THP-1 monocytic cell lineage, we aimed
to evaluate whether oxLDL induced the UPR and lipotoxic
apoptosis to the same extent in control and M2-polarised
monocyte-derived macrophages.
Results
i) Primary Cells
IL-13/Rosiglitazone induced upregulation of markers of the
M2 macrophage phenotype
Two markers of the M2 phenotype, MR and IL-1Ra [8],
underwent significant increases in mRNA expression
after treatment of human primary macrophages (hMF)
with IL-13 and rosiglitazone (see Methods; MR: 2.93 ±
1.03 basal; IL-1Ra: 3.76 ± 1.32 basal; P < 0.10 in both
cases; Figure 1a), while MCP-1 (a marker of the M1
phenotype) did not undergo any significant increase
(data not shown). Hence, cells that had undergone this
treatment were confirmed as exhibiting the M2 macro-
phage (hM2MF) phenotype. IL-13/rosiglitazone treat-
ment did not have any significant effect on cell viability
(data not shown).
The lipotoxic effects of oxLDL in M2-polarised primary
macrophages
Because ER stress-mediated apoptosis depends on acti-
vation of Caspases-3 and -7 [24,25], we sought to deter-
mine the effect of oxLDL on apoptosis using a
luminometric Caspase 3/7 assay. As shown in Figure 1c,
hM2MF exhibited significantly higher levels of oxLDL-
induced apoptosis (1 μg/ml: 2.22 ± 0.06 basal; 40 μg/ml:
7.09 ± 0.36 basal) than hMF (1 μg/ml: 1.23 ± 0.01
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hM2MF for both oxLDL doses). Similarly, as shown in
Figure 1d, hM2MF exhibited more marked oxLDL-
induced decreases in cell viability (1 μg/ml: 0.79 ± 0.04
basal; 40 μg/ml: 0.59 ± 0.02 basal), than hMF (1 μg/ml:
1.06 ± 0.03 basal; 40 μg/ml: 0.69 ± 0.07 basal; P < 0.05
hMF v. hM2MF for 1 μg/ml oxLDL; non-significant for
high oxLDL dose). Treatment with non-oxidised LDL
did not elicit any increases in apoptosis or decreases in
cell viability, whereas thapsigargin (100 nM; 24 h), a
“classical” inducer of ER stress [15], induced significant
increases in apoptosis or decreases in cell viability in
both cases (data not shown). Thus, these primary cell
data suggest that M2-polarized cells are more sensitive
than other forms of macrophage to the specific lipotoxic
effects of oxLDL.
ii) THP-1 derived cells
To elucidate the mechanism underpinning the above
effects, cells derived from the cultured monocytic THP-
1 cell line [26] were employed as models for primary
monocyte-derived macrophages. The cell types used (see
Methods section for details) were: THP-1 monocytic
cells (THP1-Mon), M2-polarized THP-1 monocytes
(THP1-M2Mon), PMA-differentiated THP-1 macro-
phages (dTHP1-MF), and M2-polarized PMA-differen-
tiated THP-1 macrophages (dTHP1-M2MF). We have
previously reported that intercalation of oxLDL-derived
Figure 1 M2 polarisation and apoptosis/cell viability in primary macrophage cell types. A: RT-PCR was used to determine relative mRNA
expression levels for the M2 markers MR (white bars) and IL-Ra (grey bars) before (’hMF’) and after (’hM2MF’) treatment of human primary
macrophages with 15 ng/mL IL-13/1 μM Rosiglitazone (72 h). n ≥ 3 in all cases; P < 0.10 where indicated. B: RT-PCR was used to determine
relative mRNA expression levels for the M2 markers MR (white bars) and IL-Ra (grey bars) in THP1-Mon (white bars), THP1-M2Mon (light grey
bars), dTHP1-MF (dark grey bars) and dTHP1-M2MF (black bars) n ≥ 3 in all cases; P < 0.05 where indicated. Spectrophotometric MTS assays (C)
and luminometric Caspase 3/7 assays (D) were used to determine cell viability and apoptosis respectively in hMF (white bars) and hM2MF
(black bars), after treatment with oxLDL (1 μg/ml or 40 μg/ml; 24 h) as indicated. n ≥ 3 in all cases.
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THP1-Mon cells alters the physico-chemical properties
of this membrane (as determined by Electron Paramag-
netic Resonance spectrometry [23]), and so disrupts ER
membrane protein function (as determined by coupled-
enzyme SERCA2b Ca
2+ATPase assays [23]).
Expression of marker genes for the M2 macrophage
phenotype
A ss h o w ni nF i g u r e1 b ,s p e c i f i cu p r e g u l a t i o no ft w oM 2
markers, MR and IL-Ra [8], was observed after 72 h
treatment of dTHP1-MF with IL-13 and rosiglitazone
(MR: 41.72 ± 1.92 basal; IL-1Ra: 25.76 ± 0.48 basal; P <
0.05 in both cases). Hence, cells that had undergone
this treatment were confirmed as exhibiting an M2
macrophage-like (dTHP1-M2MF) phenotype. In con-
trast, non-differentiated THP-1 monocytic cells
expressed both marker genes only at very low levels in
e i t h e rt h ep r e s e n c eo rt h ea b s e n c eo fI L - 1 3 / r o s i g l i t a -
zone treatment (< 0.1 of that seen in dTHP1-MF;F i g -
ure 1b). Once again, IL-13/rosiglitazone treatment did
not have any significant effect on cell viability (data not
shown).
Measurement of [Ca
2+]cyt
As shown in Figure 2, levels of resting [Ca
2+]cyt, as mea-
sured by Fluo-3AM and converted to absolute [Ca
2+]cyt
via the Grynkewickz equation [27,28], were within the
expected physiological range (i.e. < 0.1 μM; [27]), indi-
cating that this method could reliably be used for the
estimation of [Ca
2+]cyt. Under conditions of increased
ER membrane rigidity and disrupted ER membrane pro-
tein function, Ca
2+ can escape from the ER into the
cytoplasm [17,29], and in our experiments, treatment
with oxLDL (24 h) was associated with significant
increases in [Ca
2+]cyt (THP1-Mon: basal: 82 ± 17 nM; 1
μg/ml: 144 ± 30 nM; 40 μg / m l :8 5±8n M ;THP1-
M2Mon: basal: 38 ± 6 nM; 1 μg/ml: 148 ± 53 nM; 40
μg/ml: 102 ± 16 nM; dTHP1-MF:b a s a l :5 2±1 8n M ;1
μg/ml: 105 ± 33 nM; 40 μg/ml: 135 ± 6 nM; dTHP1-
M2MF:b a s a l :6 6±1 1n M ;1μg/ml: 81 ± 1 nM; 40 μg/
ml: 85 ± 4 nM (P < 0.05 v. control in all cases, with the
exception of THP1-Mon/40 μg/ml oxLDL, where only a
non-significant increase was seen)). 100 nM thapsigargin
induced significant increases in [Ca
2+]cyt in all cases
(data not shown). Thus, oxLDL appeared to disrupt
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Figure 2 The effects of oxLDL on cytoplasmic Ca
2+ concentrations in THP1-derived monocyte-macrophage cell-types.F l u o 3 - m e d i a t e d
fluorimetric quantitation of [Ca
2+]cyt in THP1-Mon (white bars), THP1-M2Mon (light grey bars), dTHP1-MF (dark grey bars) and dTHP1-M2MF
(black bars), after treatment with oxLDL (1 μg/ml or 40 μg/ml; 24 h) as indicated. n ≥ 3 in all cases; P < 0.05 where indicated.
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2+ homeostasis, presumably via its actions on
the ER, in all 4 cell types.
Oxidized LDL-induced activation of XBP-1
As alternative splicing (and hence activation) of the UPR
transcription factor XBP-1 mRNA is an indicator of activa-
tion of the UPR in response to ER Stress [17], we employed
the methods of Shang et al [30] to investigate XBP-1 spli-
cing. Densitometric analysis showed neither 1 μg/ml nor
40 μg/ml oxLDL (24 h in both cases) induced XBP-1 acti-
vation in THP1-Mon, while in THP1-M2Mon (Figure 3b)
there was XBP-1 activation only at high concentrations of
oxLDL (40 μg/ml: 1.79 ± 0.20 basal, P < 0.05). In contrast,
both oxLDL doses induced statistically significant XBP-1
activation in dTHP1-MF (1 μg/ml: 1.28 ± 0.12 basal; 40
μg/ml: 2.08 ± 0.24 basal; P < 0.05 in both cases; Figure 3c),
and dTHP1-M2MF cells (1 μg/ml: 1.60 ± 0.20 basal; 40
μg/ml: 1.80 ± 0.20 basal; P < 0.05 in both cases; Figure 3d).
As shown in Figure 3, thapsigargin (100 nM; 24 h) induced
significantly greater activation in all cases.
Determination of mRNA expression levels for the XBP-1
Target Genes BiP and CHOP
To confirm the previous identification of BiP and CHOP as
UPR target genes ([18,19]; Figure 4a), we carried out bioin-
formatics screens of the BiP (Accession No: NM_005347.3)
and CHOP (Accession No: NM_001195055.1)g e n e
sequences. These revealed that within the 5’UTR of the BiP
are three ER stress response elements (ERSEs) conforming
to the consensus sequence CCAAT(n)xCCACA [18] at
positions
-283,
-316 and
-348, while within the CHOP 3’UTR
is an ERSE conforming to the same consensus sequence
[18] at position
+661.
We then investigated the effects exerted by treatment
with oxLDL (24 h) on expression of BiP and CHOP; while
no oxLDL-induced BiP mRNA induction could be
observed in THP1-Mon, oxLDL upregulated BiP at high
oxLDL doses in THP1-M2Mon (40 μg/ml: 1.81 ± 0.13
basal (P < 0.05)) and dTHP1-MF (40 μg/ml: 1.58 ± 1.20
basal (P < 0.05)), and at both oxLDL doses in dTHP1-
M2MF (1 μg/ml: 1.64 ± 0.40 basal; 40 μg/ml: 1.44 ± 0.28
basal (P < 0.05 in both cases)). Additionally, as shown in
Figure 4b, oxLDL induced only non-significant CHOP
upregulation in THP1-Mon, THP1-M2Mon and dTHP1-
MF. In contrast, in dTHP1-M2MF, low oxLDL doses
induced non-specific increases in CHOP expression (1.40
± 0.68 basal; P > 0.05), while high oxLDL doses signifi-
cantly upregulated CHOP (3.09 ± 0.93 basal; P < 0.05).
100 nM thapsigargin induced significantly greater BiP/
CHOP upregulation in all cases (data not shown).
oxLDL-induced ER stress-mediated apoptosis and
decreased cell viability
Because ER stress-mediated apoptosis depends on activa-
tion of Caspases-3 and -7 [24,25], we sought to determine
the effect of oxLDL on apoptosis using a luminometric
Caspase 3/7 assay (Figure 5a). Treatment with oxLDL did
not induce apoptosis in THP1-Mon or THP1-M2Mon,
and induced only small non-significant increases in apop-
tosis in dTHP1-MF. However, in dTHP1-M2MF, oxLDL
induced statistically significant increases in apoptosis
(1 μg/ml: 1.97 ± 0.12 basal; 40 μg/ml: 2.29 ± 0.10 basal; P
< 0.05 in both cases). Finally, the impact of oxLDL-
induced apoptosis on cell viability was investigated: as
shown in Figure 5b, no significant decrease in cell viabi-
lity was observed with either oxLDL dose in either
THP1-Mon or THP1-M2Mon. In contrast, both 1 and 40
μg/ml oxLDL induced relatively small decreases in cell
viability in dTHP1-MF (1 μg/ml: 0.78 ± 0.07-fold, P <
0.05; 40 μg/ml: 0.85 ± 0.15-fold; P > 0.05), while inducing
more marked decreases in cell viability in dTHP1-
M2MF (1 μg/ml: 0.67 ± 0.02-fold; 40 μg/ml: 0.58 ± 0.02-
fold; P < 0.05 in both cases; Figure 5b). 100 nM thapsi-
gargin induced significantly greater increased apoptosis
or decreased cell viability in all cases (data not shown).
As with primary monocyte-derived macrophages, treat-
ment with non-oxidised LDL did not elicit any increases
in apoptosis or decreases in cell viability (data not
shown).
Importantly, it should be noted that, with regard to
apoptosis and cell viability, oxLDL-treated dTHP1-
M2MF responded to a significantly greater extent than
other cell-types (P < 0.05 v. oxLDL-treated THP1-Mon,
THP1-M2Mon or dTHP1-MF; Figure 5).
Discussion
T h ec u r r e n ts t u d yp r e s e n t sd a t ai n d i c a t i n gt h a tM 2 -
polarised macrophages are more sensitive to the lipotoxic
effects of oxLDL than other forms of monocyte/macro-
phage. The effects of oxLDL on disruption of ER Ca
2+
homeostasis, activation of the UPR transcription factor
XBP-1, upregulation of the UPR target genes BiP and
CHOP, and on apoptosis and cell viability, were deter-
mined in six cell types: hMF,h M 2 M F,T H P 1 - M o n ,
THP1-M2Mon, dTHP1-MF,a n dd T H P 1 - M 2 M F.W i t h
regard to these parameters, a consistent pattern was
observed: THP1-Mon were the least sensitive to oxLDL,
while hM2MF and dTHP1-M2MF were the most sensi-
tive, with hMF, dTHP1-MF and THP1-M2Mon being
intermediate in their sensitivity. Importantly, the M2-
polarised macrophages (hM2MF and dTHP1-M2MF)
were the only cell types to undergo significantly increased
apoptosis and decreased cell viability when exposed to
oxLDL levels similar to those seen in the circulation of
overweight individuals (ie. ~1 μg/ml - as seen in indivi-
duals with a body mass index of 25-30 kg/m
2 [31]).
The source of oxLDL-induced lipotoxicity in this
instance is likely to be cholesterol, a component of
oxLDL particles. It has been known for many years that
intracellular accumulation of cholesterol results when
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Page 5 of 12macrophages take in more lipid than can be excreted;
lysosomal cholesterol esterases are responsible for the
generation of free cholesterol from lipoprotein-derived
cholesteryl esters, and a proportion of the resulting free
cholesterol is trafficked to intracellular membranes such
as the ER membrane [32]. The ER membrane is a narrow,
fluid structure containing < 10% cholesterol [33];
elevation of its cholesterol content results in a broader,
less fluid structure which restricts the ability of ER inte-
gral membrane proteins to undergo conformational
movements and so catalyse their respective enzymatic
reactions [22,23]. This results in disrupted ER function
[23], and the resulting ER stress has been linked via the
UPR/CHOP pathway to the triggering of apoptosis
Figure 3 oxLDL-induced XBP-1 Activation in THP1-derived monocyte-macrophage cell-types.R e p r e s e n t a t i v ei m a g e s( i n s e t s )a n d
densitometric summaries from agarose gels used to determine XBP-1 activation in THP1-Mon (A), THP1-M2Mon (B), dTHP1-MF (C) and dTHP1-
M2MF (D) after treatment with oxLDL (1 μg/ml or 40 μg/ml; 24 h) or thapsigargin (100 nM; 24 h) as indicated. n ≥ 3 in all cases; P < 0.05 where
indicated.
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Page 6 of 12Figure 4 oxLDL-induced upregulation of the UPR target genes BiP and CHOP in THP1-derived monocyte-macrophage cell-types. Semi-
quantitative determination of BiP (A) and CHOP (B) mRNA levels in THP1-Mon (white bars), THP1-M2Mon (light grey bars), dTHP1-MF (dark grey
bars) and dTHP1-M2MF (black bars), after treatment with oxLDL (1 μg/ml or 40 μg/ml; 24 h) as indicated. n ≥ 3 in all cases; P < 0.05 where
indicated.
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Figure 5 The effects of oxLDL on apoptosis and cell viability in THP1-derived monocyte-macrophage cell-types. Luminometric Caspase
3/7 and spectrophotometric MTS assays were used to determine apoptosis (A) and cell viability (B) respectively in THP1-Mon (white bars), THP1-
M2Mon (light grey bars), dTHP1-MF (dark grey bars) and dTHP1-M2MF (black bars), after treatment with oxLDL (1 μg/ml or 40 μg/ml; 24 h) as
indicated. n ≥ 3 in all cases; P < 0.05 where indicated.
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Results section), CHOP mRNA can be induced by pro-
longed and/or severe ER stresses to act as a transcription
factor that controls several genes associated with apopto-
sis, including Bcl-2, GADD34, TRB3 and several cas-
pases, including caspases 3 and 7 [19]. (NB. It should be
noted that the autophagic pathway, which can lead to
non-apoptotic cell death by engulfing, degrading and
recycling of cell organelles and proteins [34], is also asso-
ciated with ER stress [35]; because in the present study,
lipotoxic cell death associated with UPRs was assessed
solely by determination of CHOP expression and caspase
3/7 activity, the possibility cannot be ruled out that other
forms of cell death may also play a role in obesity-related
macrophage phenotypic shifts. Nevertheless, in line with
several previous papers [19-22], the current study has
focused on CHOP-mediated a p o p t o s i sa st h ep r e d o m i -
nant mode of lipotoxic cell death in macrophages.)
As stated above, several mechanisms that may contri-
bute to the obesity-linked shift to predominantly M1 cells
been identified [1,11]. However, additional mechanism(s)
may also underpin the M2-to-M1 shifts seen within pre-
existing macrophage populations during the development
of obesity [4], and as described above, lipotoxicity has
recently been proposed as a potential mechanism by
which such shifts may occur [15]. In the light of our
demonstration that M2 macrophages exhibit higher sensi-
tivity to oxLDL-induced lipotoxicity than non-M2-
polarised macrophages, we propose that a higher degree of
oxLDL-induced lipotoxic cell death within M2 macro-
phages may contribute to the decrease in numbers of M2
cells. Over time, a relative increase in proportion of non-
M2 cells and hence a predominantly M1 macrophage
population would ensue, leading to development of a
more pro-inflammatory milieu in the tissues of obese
individuals.
Having demonstrated heightened sensitivity to oxLDL-
induced lipotoxicity in M2-polarised macrophages, we
next considered the possible sources of this heightened
sensitivity (ie. we addressed the question: “At what point
in the ER stress/lipotoxicity pathway do M2 cells become
more sensitive?“). There were no significant differences in
oxLDL’si m p a c to n[ C a
2+]cyt in the different cell types
(Figure 2), and dTHP1-M2MF did not react to a greater
extent than dTHP1-MF in terms of XBP-1 activation
(Figure 3). However, significant increases in BiP expression
(cf. THP1-Mon) were only seen in dTHP1-M2MF after
treatment with 1 μg/ml oxLDL, with only non-significant
increases being seen in other cell types (Figure 4a). More-
over, as shown in Figure 4b, statistically significant
increases in CHOP expression were seen only in dTHP1-
M2MF after treatment with 40 μg/ml oxLDL (a similar
pattern was seen in the case of 1 μg/ml oxLDL v. CHOP,
albeit without attaining statistical significance). Finally,
with regard to apoptosis and cell viability, the response of
dTHP1-M2MF to oxLDL was significantly greater than
the comparable responses of other THP-1 derived cell-
types (Figure 5). As stated above, with regard to primary
cells, the same general pattern was observed: hM2MF
exhibited significantly more apoptosis and less cell viability
than hMF when exposed to oxLDL levels similar to those
seen in sedentary individuals (i.e. 1 μg/ml [31]; Figures 1c
and 1d). Thus, it appears that a factor relevant to the UPR
(perhaps involving differences in the ability of the UPR to
restore normal cell physiology and so avoid the triggering
of apoptosis) may be the source of M2-polarised cells’
heightened lipotoxic sensitivity. Further elucidation of the
source of this differential lipotoxicity may increase our
understanding of the causal connections between obesity
and inflammatory diseases such as T2D; however, defini-
tive identification of this source is unfortunately beyond
the scope of this preliminary study.
As stated above, macrophages are involved in lipid accu-
mulation in a wide variety of tissues, including adipose tis-
sue [12]. Intriguingly, quantitation of lipid-loading in
different macrophage subtypes during the progression of
obesity in ob/ob mice fed a high-fat diet revealed that,
while macrophage lipid-loading in general increased, very
few lipid-loaded M2 macrophages could be identified,
with lipid-loading and adoption of a foam cell-like appear-
ance being characteristic only of M1 macrophages [15].
One may speculate that this could be explained by an
inability of M2 macrophages to tolerate large quantities of
intracellular lipid, and thus increased M2 cell death in a
high-lipid environment. Such an explanation could also
account for the high levels of apoptosis and M1-predomi-
nant nature of the macrophage foam cell populations resi-
dent in the unstable regions surrounding the lipid cores of
atherosclerotic plaques [8,21]. Thus, the relevance of dif-
ferential macrophage lipotoxicity is likely to extend
beyond adipose tissue macrophages. For example, the M2-
to-M1 shift seen in Kupffer cells during the progression of
liver steatosis has recently led Mandal et al to suggest that
“changes in the M1/M2 phenotypic balance can impact on
diverse disease conditions“ [36], a statement which lends
increased importance to the need to understand the
mechanism(s) by which macrophage polarisation can be
affected by phenomena such as lipotoxicity.
Clearly, there are several limitations to the current study
(eg. the exclusively in vitro nature of the experiments; the
lack of direct characterisation of differences in cholestero-
l®ER trafficking in each cell type). In particular, although
the current study has specifically investigated the lipotoxic
effects of oxLDL (and demonstrated that non-oxidised
LDL is not associated with the same effects), it should also
be recognised that in vivo, macrophages will be exposed to
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different lipids have demonstrated the need to both acti-
vate the UPR/CHOP pathway and engage a scavenger
receptor if apoptosis is to be triggered [20], suggesting that
only lipoproteins that are ligands for scavenger receptors
can trigger lipotoxic cell death. However, more recent stu-
dies have employed a lipidomic approach and found that a
variety of lipid species underwent obesity-associated
increases in levels within adipose tissue macrophages, and
were associated with shifts towards the M1 phenotype;
amongst these lipids were free cholesterol and saturated
fatty acids [15]. Interestingly, the relatively rigid inflexible
structures of both these lipids are compatible with disrup-
tion of ER membrane functions, and thus the triggering of
the UPR. Meanwhile, lipids with more flexible structures
that would not be expected to disrupt ER membrane prop-
erties (eg. polyunsaturated fatty acids, plasmalogens) were
n o ta s s o c i a t e dw i t hi n c r e a s es in the M1 subtype [15].
Thus, a capacity for triggering ER stress/UPR-linked apop-
tosis - and possibly a consequent heightened degree of
damage to M2-polarised cells, which appear to be more
sensitive to lipotoxicity - may underpin the detrimental
effects of a variety of harmful lipids (including, but not
limited to, oxLDL). Further studies are required to estab-
lish whether this is the case.
Conclusion
Given the elevated levels of circulating oxLDL and other
lipids seen in obesity [2] (and hence the increased likeli-
hood of the in vitro effects seen here occurring in the tis-
sues of an obese individual in vivo), and also the
importance of M1 macrophage-mediated inflammation in
the pathogenesis of obesity-related diseases such as T2D
and atherosclerosis [3], the current study’s demonstration
that M2-polarised macrophages are more sensitive to the
UPR-mediated lipotoxic effects of oxLDL than other
forms of monocyte/macrophag em a yc o n s t i t u t eau s e f u l
contribution to our understanding of the origin of the
pro-inflammatory nature of obesity, and of the pathogen-
esis of obesity-associated disorders such as T2D and
atherosclerosis.
Materials & methods
Materials
All reagents were purchased from Sigma-Aldrich (Poole,
UK) unless stated otherwise. oxLDL, rosiglitazone,
GW9662 and IL-13 were obtained from Autogen Bio-
clear (Calne, UK), GlaxoSmithKline (Uxbridge, UK) and
R&D Systems (Abingdon, UK), respectively. Human pri-
mary monocyte-macrophages and human monocytic
THP-1 cell lines were obtained from the Welsh Blood
Transfusion Service (Llantrisant, UK) and European Col-
lection of Cell Cultures (Salisbury, UK), respectively.
Generation of primary human monocyte-derived
macrophages
Primary human monocyte-derived macrophages were
obtained via the method of Iwashima et al [37]. Briefly, 10
ml of heparinised blood was diluted 1:1 in RPMI medium,
layered over 10 ml of Histopaque-1077 Ficoll-Hypaque
and centrifuged at 400 × G for 20 min. The mononuclear
cell suspension was carefully removed from the Ficoll-
Hypaque interface, and washed four times (500 × G;
10 min) in Phosphate-Buffered Saline (PBS), and mono-
nuclear cells were then incubated (37°C; 5% CO2) for 2 h,
after which non-adherent cells (representing non-mono-
cytes) were removed by discarding the media. Following
adhesion to tissue culture plasticware for 7 days (with
medium being changed every 48 h), monocytes were con-
sidered to have differentiated to human primary macro-
phages (hMF). M2-polarized macrophages (hM2MF)
were then obtained via the method of Bouhlel et al [8], in
which treatment for 72 h with 15 ng/ml IL-13 and 1 μM
rosiglitazone induced M2 polarization.
Maintenance of THP-1 cells in culture
Human THP-1 cells [25] were manipulated in culture in
order to generate four distinct cell types: human THP-1
monocytic cells (THP1-Mon), M2-polarized THP-1
monocytes (THP1-M2Mon), PMA-differentiated THP-1
macrophages (dTHP1-MF), and M2-polarized PMA-dif-
ferentiated THP-1 macrophages (dTHP1-M2MF). To
generate THP1-M2Mon, dTHP1-MF,a n dd T H P 1 -
M2MF, the methods of Tjiu et al [38] and Bouhlel et al
[8] were followed, with minor modifications: (a) THP1-
M2Mon: THP-1Mon cells were treated for 72 h with 15
ng/ml IL-13 and 1 μM rosiglitazone; (b) dTHP1-MF:
THP-1Mon cells were treated with 100 ng/ml PMA for 72
h; cells that adopted an adherent macrophage-like pheno-
type were selected as THP1MF;( c )dTHP1-M2MF:
THP-1Mon cells were pre-incubated with 100 ng/ml
PMA for 6 h before addition of 15 ng/ml IL-13/1 μMr o s i -
glitazone for the remaining 66 h of a total incubation time
of 72 h.
Cell treatments
hMF,h M 2 M F, THP1-Mon, THP1-M2Mon, dTHP1-
MF,a n dd T H P 1 - M 2 M F were treated for 24 h with 1
μg/ml oxLDL (which approximates to serum oxLDL
levels seen in overweight individuals (ie. those with a
body mass index of 25-30 kg/m
2)[ 3 1 ] )o r4 0μg/ml
oxLDL (a commonly-used supra-physiological dose [39]).
In some cases, control samples were treated with non-
oxidised LDL, or with thapsigargin (100 nM) as a positive
control for disruption of ER homeostasis [16], respec-
tively. Data were expressed for each sample in compari-
son to the readings obtained in basal samples (ie. cells of
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with oxLDL).
Measurement of resting cytoplasmic Ca
2+ concentrations
([Ca
2+]cyto)
[Ca
2+]cyto was measured by the method of Elsner [26], in
which fluo-3 fluorescence was used as an indicator of rest-
ing [Ca
2+]cyto. Adherent cells seeded into the wells of opa-
que-walled multi-well plates, (dTHP1-MF,d T H P 1 -
M2MF; approx 5 × 10
3 cells per sample), or cell suspen-
sions (THP1-Mon, THP1-M2Mon; 7 × 10
6/ml in RPMI
1640) were pre-incubated with 1 or 40 μg/ml oxLDL for
24 h at 37°C, and then incubated with 3 μMf l u o - 3 / A M
(Molecular Probes, Eugene, OR) for 40 min at 37°C before
washing twice with PBS; THP-1Mon and M2Mon samples
were resuspended in RPMI 1640 at a final concentration
of 1 × 10
6/ml. Cell samples in multi-well plates were read
using a Tecan Infinite
®200 multimode microplate fluori-
meter with a FITC filter (lex = 490 nm; lem = 520 nm;
Tecan, Dorset, UK). Using the Grynkiewicz equation, and
previously reported values for Fluo-3’s association con-
stant with Ca
2+ [27,28], fluorescence readings were then
estimated as absolute Ca
2+ concentration data.
RNA extraction, and XBP-1 activation or gene expression
RT-PCR assays
In all cases, total RNA from hMF, hM2MF, THP1-Mon,
THP1-M2Mon, dTHP1-MF,a n dd T H P 1 - M 2 M F (±
treatment with oxLDL or thapsigargin for 24 h as
described above) were extracted with Trizol
® Reagent
(Invitrogen, Paisley, UK), and RNA samples were con-
verted to cDNA using an Applied Biosystems
® High-
Capacity cDNA Reverse transcription Kit (Invitrogen,
Paisley, UK), according to the manufacturer’s instructions.
Activation of the UPR transcription factor XBP-1 was
assessed via Shang’s method [30], which uses RT-PCR,
agarose gel electrophoresis and densitometric analysis to
determine XBP-1 activation. Because Ire1’se n d o r i b o n u -
clease activity excises a 44 bp segment from within exon 4
of the unspliced XBP-1 mRNA species (XBP-1(u); Acces-
sion No: NM_005080.3) under conditions of ER stress,
and so generates a spliced mRNA (XBP-1(s); Accession
No: NM_001079539.1) encoding the active form of the
protein [14], XBP-1 activation was determined via densito-
metric analysis of banding patterns on 2% agarose gels by
means of the following formula “[XBP-1(s)+0.5 XBP-1
(h)]/[XBP-1(s)+XBP-1(h)+XBP-1(u)]“, where XBP-1(s) is
a 398 bp PCR product, XBP-1(u) is a 442 bp PCR product,
and XBP-1(h) is an additional PCR product representing a
heteroduplex XBP-1 cDNA species [30]. In all cases, XBP-
1 activation was then expressed relative to that seen in
control THP-1Mon cells.
For gene expression assays, expression of genes of
interest (see below) was determined using SYBR
® Green
or Taqman
® Gene Expression Assays and an Applied
Biosystems 7500 Real-time PCR system (Applied Biosys-
tems, Warrington, UK). In the case of MR, IL-1Ra and
CHOP, semi-quantitative (relative to b-actin and/or Gly-
ceraldehyde Phosphate Dehydrogenase (GAPDH))
SYBR
® Green assays were carried out using the follow-
ing primers:
MR: Fwd: 5’-CCATGGACAATGCGCGAGCG-3’
Rev: 5’-CACCTGTGGCCCAAGACACGT-3’
I L - 1 R a :F w d :5 ’-GGCCTCCGCAGTCACCTAATCAC-3’
Rev: 5’-GGACAGGCACATCTTCCCTCCAT-3’
C H O P :F w d :5 ’-GCGTCTAGAATGGCAGCTGAGT-
CATTGCC-3’
Rev: 5’-GCGTCTAGATCATGCTTGGTGCA-
GATTC-3’
b-actin: Fwd: 5’-TCCTGTGGCATCCACGAA-3’
Rev: 5’-GAAGCATTTGCGGTGGAC-3’
GAPDH: Fwd: 5’-ATGTTCCAGTATGACTCCACT-
CACG-3’
Rev: 5’-GAAGACACCAGTAGACTCCACGACA-3’
In the case of BiP, mRNA expression was assessed semi-
quantitatively (relative to GAPDH) via Taqman
® Gene
Expression Assays (Applied Biosystems, Warrington, UK)
for BiP (Gene Expression Assay Hs99999174_m1) and
GAPDH (Gene Expression Assay Hs99999905_m1).
Cell viability and apoptosis Assays
Cell viability and apoptosis levels within hMF,h M 2 M F,
THP1-Mon, THP1-M2Mon, dTHP1-MF,a n dd T H P 1 -
M2MF samples (± treatment with oxLDL for 24 h as
described above) was determined using 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide
(MTS) and Caspase-Glo 3/7 assays (Promega, Southamp-
ton, UK), respectively, according to the manufacturers’
instructions. The resulting absorbance or luminescence
data was read via Dynex plate-reading spectrophotometer
or luminometer (Worthing, UK), respectively.
Statistical analysis
Data are expressed as mean ± standard error of the
mean. Statistical significance was determined via
ANOVA or 2-sample t-tests as appropriate; significance
levels were set at P < 0.05 except where stated
otherwise.
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